Myelodysplastic Syndromes (MDS) and pregnancy are a rare combination and as such, there remains limited recommendations for treatment of this special population of patients. In this paper, we present 2 clinical cases to provide theoretical decision making for management of pregnancy in the setting of MDS based on expert opinion and accumulation of available data. We outline additional considerations and workup to help guide providers in successful management of this complex clinical dilemma.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1053/j.seminhematol.2024.11.001 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!